VirTra (VTSI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Q3 2024 revenue was $7.5 million, nearly flat year-over-year, with a 23% sequential increase and nine-month revenue of $21.7 million, down 22% due to delayed contracts and sales team rebuilding.
Bookings surged to $8.9 million in Q3, up 51% sequentially and 22% year-over-year, with backlog at $15.2 million at quarter-end.
Gross margin improved to 73% in Q3 and 76% for the nine months, driven by operational efficiencies and higher-margin contracts.
Net income for Q3 was $0.6 million ($0.05 per diluted share), down 64% year-over-year due to higher operating expenses.
VXR platform rollout advanced, targeting new markets such as healthcare and education, with strong early interest.
Financial highlights
Q3 revenue: $7.5 million (down 1% year-over-year); nine-month revenue: $21.7 million (down 22%).
Q3 gross profit: $5.5 million (73% margin); nine-month gross profit: $16.5 million (76% margin, up from 65% YoY).
Q3 net income: $0.6 million ($0.05 per diluted share), down from $1.6 million ($0.15 per share) YoY; nine-month net income: $3.0 million, down 47%.
Adjusted EBITDA for Q3: $1.1 million (down 62% YoY); nine-month Adjusted EBITDA: $4.7 million (down 50% YoY).
Unrestricted cash and equivalents: $19.7 million as of September 30, 2024; working capital: $36 million.
Outlook and guidance
Management expects most new capital bookings to convert to revenue in 2024, but contract delivery dates may change.
Anticipates further bookings growth as international reseller network expands and federal funding clarity improves.
Operational readiness and cash position enable flexibility to navigate funding delays and capitalize on new opportunities.
Focused on marketing, sales, and innovation to drive pipeline growth into 2025.
Current capital resources are expected to support operations for more than 12 months; open to raising additional funds for expansion.
Latest events from VirTra
- Q2 revenue fell 41% but gross margin hit 91% and bookings doubled, supporting future growth.VTSI
Q2 20241 Feb 2026 - Expanding simulation training into military and healthcare, driving growth with innovation and strong margins.VTSI
2024 Annual Gateway Conference22 Jan 2026 - Directors and auditor ratified; focus on automation, partnerships, and shareholder concerns.VTSI
AGM 202419 Jan 2026 - Bookings and backlog grew despite revenue headwinds, with margin and international gains.VTSI
Q4 202425 Dec 2025 - Registering up to $50M in securities to fund growth, leveraging patented simulation technology.VTSI
Registration Filing16 Dec 2025 - Director elections, auditor ratification, and performance-based executive pay headline the agenda.VTSI
Proxy Filing1 Dec 2025 - Shareholders will elect directors, ratify the auditor, and review robust governance and compensation.VTSI
Proxy Filing1 Dec 2025 - Five directors, including two new nominees, are up for election to ensure board independence.VTSI
Proxy Filing1 Dec 2025 - Q2 revenue up 15% year-over-year, but net income fell sharply amid margin pressure.VTSI
Q2 202523 Nov 2025